Relationship between polyautoimmunity and sarcopenic obesity in rheumatoid arthritis patients

Reumatol Clin (Engl Ed). 2022 Nov;18(9):531-537. doi: 10.1016/j.reumae.2021.06.002. Epub 2021 Dec 8.

Abstract

Objective: Sarcopenia is a major cause of morbidity in rheumatoid arthritis patients. Our purpose was to determine whether polyautoimmunity is associated with sarcopenia and alterations in whole body composition in patients with rheumatoid arthritis (RA).

Methods: We performed a cross-sectional observational study of a series of cases of RA. All patients were recruited consecutively from a rheumatology clinic. Body composition by dual-energy x-ray absorptiometry (DEXA) was assessed. The variables of interest were polyautoimmunity (RA associated with other autoimmune diseases), sarcopenia, fat mass, and body mass index (BMI). Other variables included were clinical-analytical and inflammatory cytokines and adipokines. The relationship between sarcopenic obesity and the presence of polyautoimmunity was studied using multivariate analysis.

Results: Of the 94 patients with RA included in the study, 15 (16%) had polyautoimmunity. A total of 23 patients with RA (24.5%) had sarcopenia, which was more prevalent in patients with polyautoimmunity than in patients without polyautoimmunity (46.7% vs 20.3%; p = .029). Sarcopenia was not associated with body fat content (p = .870) or with BMI (p = .998). The multivariate analysis showed the factors associated with polyautoimmunity in RA to be sarcopenia (odds ratio [95% CI], 4.80 [1.49-13.95]), BMI (1.18 [1.04-1.35]), and resistin (1.249 [1.01-1.53]).

Conclusion: Sarcopenia and obesity were more prevalent in patients with RA and polyautoimmunity. Resistin values were also higher in this group than in patients with RA without polyautoimmunity.

Keywords: Artritis reumatoide; Obesidad; Obesity; Poliautoinmunidad; Polyautoimmunity; Rheumatoid arthritis; Sarcopenia; Sarcopenic.

Publication types

  • Observational Study

MeSH terms

  • Arthritis, Rheumatoid* / complications
  • Cross-Sectional Studies
  • Humans
  • Obesity / complications
  • Resistin
  • Sarcopenia* / complications

Substances

  • Resistin